Quick Answer
Bioventus Inc. reported Total Revenue of $568.09 million for fiscal year 2025.
Bioventus Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $568.09M | -0.9% |
| 2024 | $573.28M | +11.9% |
| 2023 | $512.35M | +0.0% |
| 2022 | $512.12M | +18.8% |
| 2021 | $430.90M | +34.2% |
| 2020 | $321.16M | -5.6% |
| 2019 | $340.14M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $138.65M | -0.2% | -6.1% |
| June 30, 2025 | $147.66M | -2.4% | +19.2% |
| March 31, 2025 | $123.88M | -4.3% | -10.9% |
| September 30, 2024 | $138.96M | +15.0% | -8.1% |
| June 30, 2024 | $151.22M | +10.3% | +16.8% |
| March 31, 2024 | $129.46M | +8.7% | +7.2% |
| September 30, 2023 | $120.79M | -6.1% | -11.9% |
| June 30, 2023 | $137.07M | -2.3% | +15.1% |
- Bioventus Inc. showed a decrease of -0.9% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, Bioventus Inc.’s total revenue has grown by 67.0% (from $340.14 million to $568.09 million).
- The most recent figure is from Bioventus Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: